Unknown

Dataset Information

0

Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection.


ABSTRACT: Although prior studies have characterized the neutralizing activities of monoclonal antibodies (MAbs) against dengue virus (DENV) serotypes 1, 2, and 3 (DENV-1, DENV-2, and DENV-3), few reports have assessed the activity of MAbs against DENV-4. Here, we evaluated the inhibitory activity of 81 new mouse anti-DENV-4 MAbs. We observed strain- and genotype-dependent differences in neutralization of DENV-4 by MAbs mapping to epitopes on domain II (DII) and DIII of the envelope (E) protein. Several anti-DENV-4 MAbs inefficiently inhibited at least one strain and/or genotype, suggesting that the exposure or sequence of neutralizing epitopes varies within isolates of this serotype. Remarkably, flavivirus cross-reactive MAbs, which bound to the highly conserved fusion loop in DII and inhibited infection of DENV-1, DENV-2, and DENV-3, more weakly neutralized five different DENV-4 strains encompassing the genetic diversity of the serotype after preincubation at 37°C. However, increasing the time of preincubation at 37°C or raising the temperature to 40°C enhanced the potency of DII fusion loop-specific MAbs and some DIII-specific MAbs against DENV-4 strains. Prophylaxis studies in two new DENV-4 mouse models showed that neutralization titers of MAbs after preincubation at 37°C correlated with activity in vivo. Our studies establish the complexity of MAb recognition against DENV-4 and suggest that differences in epitope exposure relative to other DENV serotypes affect antibody neutralization and protective activity.

SUBMITTER: Sukupolvi-Petty S 

PROVIDER: S-EPMC3754038 | biostudies-literature | 2013 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection.

Sukupolvi-Petty Soila S   Brien James D JD   Austin S Kyle SK   Shrestha Bimmi B   Swayne Sherri S   Kahle Kristen K   Doranz Benjamin J BJ   Johnson Syd S   Pierson Theodore C TC   Fremont Daved H DH   Diamond Michael S MS  

Journal of virology 20130619 16


Although prior studies have characterized the neutralizing activities of monoclonal antibodies (MAbs) against dengue virus (DENV) serotypes 1, 2, and 3 (DENV-1, DENV-2, and DENV-3), few reports have assessed the activity of MAbs against DENV-4. Here, we evaluated the inhibitory activity of 81 new mouse anti-DENV-4 MAbs. We observed strain- and genotype-dependent differences in neutralization of DENV-4 by MAbs mapping to epitopes on domain II (DII) and DIII of the envelope (E) protein. Several an  ...[more]

Similar Datasets

| S-EPMC2950583 | biostudies-literature
| S-EPMC3700316 | biostudies-literature
| S-EPMC4958264 | biostudies-literature
| S-EPMC8595868 | biostudies-literature
| S-EPMC6102825 | biostudies-literature
| S-EPMC8205970 | biostudies-literature
| S-EPMC7583086 | biostudies-literature
| S-EPMC9506301 | biostudies-literature
| S-EPMC3962419 | biostudies-literature
| S-EPMC6047064 | biostudies-literature